EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes

Yi-Ting Lin, Sergi Sayols-Baixeras, Tiscar Graells, Koen F Dekkers, Gabriel Baldanzi iD, Diem Nguyen, Anders Larsson iD, Tobias Rudholm Feldreich, Nynne Nielsen, Aron C Eklund, Jacob B Holm, H Bjørn Nielsen und 7 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Yi-Ting Lin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, 141 83 Stockholm, Sweden. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Albuminuria, Diabetic Nephropathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swedish Research Council, Swedish Heart-Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Type 2 diabetes is a growing global concern with serious complications, including kidney damage and cardiovascular morbidity and mortality. Monitoring albuminuria, which is associated with these complications, is crucial in optimal diabetes management. Gut microbiota composition has been suggested to impact albuminuria, but large studies with granular data are lacking.

Methods

We investigated the relationship between 1002 gut microbial species, 1308 plasma metabolites, and albuminuria in 752 participants with type 2 diabetes from the Swedish CArdioPulmonary BioImage Study (SCAPIS). To determine the relative abundance of species, we employed deep shotgun metagenomic sequencing of fecal samples. Plasma metabolites were analyzed using mass spectrometry-based methods.

Results

We identified 3 species that were associated with albuminuria, including Sellimonas intestinalis, Eggerthellales sp., and Ellagibacter isourolithinifaciens. Two of these species were replicated in an independent prediabetic population (n = 3423) in SCAPIS. In total, 36 annotated metabolites were associated with the 3 albuminuria-signature species. Functional mapping of the signature species suggests a role in the regulation of the metabolites of imidazole propionate and trigonelline, which have previously been reported to play roles in the progression of albuminuria.

Conclusion

These findings provide additional evidence of the potential impact of microbial species and contribute to our understanding of the complex relationship between the gut microbiome, plasma metabolites, and albuminuria in individuals with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes Mellitus, Type 2AlbuminuriaDiabetic NephropathiesHumansMaleFemaleMiddle AgedAgedFecesSweden

Stichwörter der Autor:innen

albuminuriadiabetic nephropathydysbiosisgut microbiomemicrobial signaturestype 2 diabetes

Autor:innen und Institutionen

  • Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institute, 141 83 Stockholm, Sweden.
  • Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 807 Kaohsiung, Taiwan.
  • Medical Epidemiology, Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden.
  • Molecular Epidemiology, Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.
  • CIBER Cardiovascular Diseases, Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Clinical Chemistry, Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.

ORCID-Profile: Gabriel Baldanzi, Anders Larsson, Göran Bergström, Gunnar Engström, Marju Orho-Melander, Tove Fall, Johan Ärnlöv

Förderung

  • European Research Council
  • Swedish Research Council
  • Swedish Heart-Lung Foundation
  • Novo Nordic Foundation
  • Swedish Diabetes Foundation
  • Swedish Foundation for Strategic Research
  • Center for Clinical Research, Region Dalarna Sweden

Zitieren

APA

Lin, Y. T., Sayols-Baixeras, S., Graells, T., Dekkers, K. F., Baldanzi, G., Nguyen, D., Larsson, A., Feldreich, T. R., Nielsen, N., Eklund, A. C., Holm, J. B., Nielsen, H. B., Bergström, G., Smith, J. G., Malinovschi, A., Engström, G., Orho-Melander, M., Fall, T., & Ärnlöv, J. (2026). Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf453

Vancouver

Lin YT, Sayols-Baixeras S, Graells T, Dekkers KF, Baldanzi G, Nguyen D, et al. Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf453

BibTeX
@article{Lin2026,
  author = {Lin, Yi-Ting and Sayols-Baixeras, Sergi and Graells, Tiscar and Dekkers, Koen F and Baldanzi, Gabriel and Nguyen, Diem and Larsson, Anders and Feldreich, Tobias Rudholm and Nielsen, Nynne and Eklund, Aron C and Holm, Jacob B and Nielsen, H Bjørn and Bergström, Göran and Smith, J Gustav and Malinovschi, Andrei and Engström, Gunnar and Orho-Melander, Marju and Fall, Tove and Ärnlöv, Johan},
  title = {Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf453}
}
Kostenlos starten →